Correlation Between Pfizer and Sunshine Biopharma

Can any of the company-specific risk be diversified away by investing in both Pfizer and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Pfizer and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Sunshine Biopharma.

Diversification Opportunities for Pfizer and Sunshine Biopharma

-0.6

Correlation Coefficient

Pfizer  Sunshine Biopharma

Excellent diversification

The 3 months correlation between Pfizer and Sunshine is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Pfizer i.e., Pfizer and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Pfizer and Sunshine Biopharma

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Sunshine Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 16.04 times less risky than Sunshine Biopharma. The stock trades about -0.08 of its potential returns per unit of risk. The Sunshine Biopharma Warrant is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  9.51  in Sunshine Biopharma Warrant on August 31, 2024 and sell it today you would earn a total of  7.49  from holding Sunshine Biopharma Warrant or generate 78.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	90.48%
Values	Daily Returns

Pfizer Inc  vs.  Sunshine Biopharma Warrant

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest sluggish performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Sunshine Biopharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma Warrant are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Sunshine Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Sunshine Biopharma

The main advantage of trading using opposite Pfizer and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.

The idea behind Pfizer Inc and Sunshine Biopharma Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.